US5869054A
(en)
*
|
1987-06-24 |
1999-02-09 |
Autoimmune Inc. |
Treatment of multiple sclerosis by oral administration of autoantigens
|
US5641474A
(en)
*
|
1987-06-24 |
1997-06-24 |
Autoimmune, Inc. |
Prevention of autoimmune diseases by aerosol administration of autoantigens
|
US5645820A
(en)
*
|
1987-06-24 |
1997-07-08 |
Autoimmune, Inc. |
Treatment of autoimmune diseases by aerosol administration of autoantigens
|
US5571500A
(en)
*
|
1987-06-24 |
1996-11-05 |
Autoimmune, Inc. |
Treatment of autoimmune diseases through administration by inhalation of autoantigens
|
US5571499A
(en)
*
|
1987-06-24 |
1996-11-05 |
Autoimmune, Inc. |
Treatment of autoimmune diseases by aerosol administration of autoantigens
|
US6113903A
(en)
*
|
1989-03-21 |
2000-09-05 |
The Immune Response Corporation |
Peptides and methods against diabetes
|
IL99699A
(en)
|
1990-10-10 |
2002-04-21 |
Autoimmune Inc |
Drug with the option of oral, intra-intestinal, or inhaled dosing for suppression of autoimmune response associated with type I diabetes
|
US7448375B2
(en)
*
|
1993-01-29 |
2008-11-11 |
Aradigm Corporation |
Method of treating diabetes mellitus in a patient
|
US6024090A
(en)
*
|
1993-01-29 |
2000-02-15 |
Aradigm Corporation |
Method of treating a diabetic patient by aerosolized administration of insulin lispro
|
US5891435A
(en)
*
|
1993-04-16 |
1999-04-06 |
Research Corporation Technologies, Inc. |
Methods and compositions for delaying or preventing the onset of autoimmune disease
|
US5830853A
(en)
|
1994-06-23 |
1998-11-03 |
Astra Aktiebolag |
Systemic administration of a therapeutic preparation
|
US20010003739A1
(en)
*
|
1993-06-24 |
2001-06-14 |
Astrazeneca Ab |
Systemic administration of a therapeutic preparation
|
TW402506B
(en)
|
1993-06-24 |
2000-08-21 |
Astra Ab |
Therapeutic preparation for inhalation
|
US6632456B1
(en)
|
1993-06-24 |
2003-10-14 |
Astrazeneca Ab |
Compositions for inhalation
|
IS1796B
(is)
*
|
1993-06-24 |
2001-12-31 |
Ab Astra |
Fjölpeptíð lyfjablanda til innöndunar sem einnig inniheldur eykjaefnasamband
|
US6794357B1
(en)
*
|
1993-06-24 |
2004-09-21 |
Astrazeneca Ab |
Compositions for inhalation
|
GB9319429D0
(en)
*
|
1993-09-21 |
1993-11-03 |
London Health Ass |
Methods and products for controlling immune responses in mammals
|
US6165976A
(en)
|
1994-06-23 |
2000-12-26 |
Astra Aktiebolag |
Therapeutic preparation for inhalation
|
US6524557B1
(en)
|
1994-12-22 |
2003-02-25 |
Astrazeneca Ab |
Aerosol formulations of peptides and proteins
|
DE69530519T2
(de)
|
1994-12-22 |
2004-03-04 |
Astrazeneca Ab |
Parathyroidhormon pth enthaltende therapeutische zubereitung zur inhalation
|
EE9700138A
(et)
|
1994-12-22 |
1997-12-15 |
Astra Aktiebolag |
Aerosoolravimvormid
|
US6428771B1
(en)
*
|
1995-05-15 |
2002-08-06 |
Pharmaceutical Discovery Corporation |
Method for drug delivery to the pulmonary system
|
DE69630527T2
(de)
|
1995-06-30 |
2004-08-05 |
Novo Nordisk A/S |
Vorbeugung einer krankheit mit diabetes charakter
|
US6488933B2
(en)
|
1995-07-05 |
2002-12-03 |
Yeda Research And Development Co. Ltd. |
Preparations for the treatment of T cell mediated diseases
|
US5856446A
(en)
*
|
1995-07-07 |
1999-01-05 |
Autoimmune Inc. |
Method of treating rheumatoid arthritis with low dose type II collagen
|
WO1997009061A1
(en)
*
|
1995-09-06 |
1997-03-13 |
Alexion Pharmaceuticals, Inc. |
Treatment of diabetes via administration of hormonally ineffective insulin
|
SE520392C2
(sv)
*
|
1996-09-27 |
2003-07-01 |
Creative Peptides Sweden Ab C |
Specifika peptider för behandling av diabetes mellitus
|
US20050025758A1
(en)
*
|
1996-10-01 |
2005-02-03 |
Harrison Leonard Charles |
Method and compositions for treatment of insulin-dependant diabetes mellitus
|
JP2001511187A
(ja)
*
|
1997-02-28 |
2001-08-07 |
エンゾー セラピュウティクス, インコーポレイテッド |
選択的免疫ダウンレギュレーション(sidr)を行う新規プロセス
|
US5948407A
(en)
*
|
1997-03-19 |
1999-09-07 |
Shire Laboratories Inc. |
Oral induction of tolerance to parenterally administered non-autologous polypeptides
|
DE19733651A1
(de)
*
|
1997-08-04 |
1999-02-18 |
Boehringer Ingelheim Pharma |
Wässrige Aerosolzubereitungen enthaltend biologisch aktive Markomoleküle und Verfahren zur Erzeugung entsprechender Aerosole
|
US20060239930A1
(en)
*
|
1997-08-04 |
2006-10-26 |
Herbert Lamche |
Process for nebulizing aqueous compositions containing highly concentrated insulin
|
US6068844A
(en)
*
|
1997-12-19 |
2000-05-30 |
The United States Of America As Represented By The Department Of Health And Human Services |
Increased resistance to stroke by developing immunologic tolerance to myelin or components thereof
|
US5945123A
(en)
*
|
1998-04-02 |
1999-08-31 |
K-V Pharmaceutical Company |
Maximizing effectiveness of substances used to improve health and well being
|
US20040062802A1
(en)
*
|
1998-04-02 |
2004-04-01 |
Hermelin Victor M. |
Maximizing effectiveness of substances used to improve health and well being
|
IL126447A
(en)
*
|
1998-10-04 |
2004-09-27 |
Vascular Biogenics Ltd |
An immune preparation that confers tolerance in oral administration and its use in the prevention and / or treatment of atherosclerosis
|
US20050197283A1
(en)
*
|
1998-10-04 |
2005-09-08 |
Vascular Biogenics Ltd. |
Compositions containing beta 2-glycoprotein I for the prevention and/or treatment of vascular disease
|
US20060171899A1
(en)
*
|
1998-12-10 |
2006-08-03 |
Akwete Adjei |
Water-stabilized aerosol formulation system and method of making
|
US6417208B1
(en)
*
|
1999-02-05 |
2002-07-09 |
Albert Einstein College Of Medicine Of Yeshiva University |
Method of identification of inhibitors of PDE1C
|
US7534605B2
(en)
|
1999-06-08 |
2009-05-19 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
CD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases
|
CA2274414A1
(en)
*
|
1999-06-11 |
2000-12-11 |
Universite Laval |
Dietary fish protein for use in restoring normal insulin function insulin-resistant individuals
|
US9006175B2
(en)
|
1999-06-29 |
2015-04-14 |
Mannkind Corporation |
Potentiation of glucose elimination
|
PT1196430E
(pt)
*
|
1999-06-29 |
2012-04-18 |
Mannkind Corp |
Purificação e estabilização de péptidos e proteínas em agentes farmacêuticos
|
US6540982B1
(en)
*
|
2000-01-25 |
2003-04-01 |
Aeropharm Technology Incorporated |
Medical aerosol formulation
|
US20100303769A1
(en)
*
|
2000-04-06 |
2010-12-02 |
Franco Wayne P |
Combination growth factor therapy and cell therapy for treatment of acute and chronic heart disease
|
US7166280B2
(en)
*
|
2000-04-06 |
2007-01-23 |
Franco Wayne P |
Combination growth factor therapy and cell therapy for treatment of acute and chronic heart disease
|
US6543682B1
(en)
|
2000-05-03 |
2003-04-08 |
Nichole Glaser |
Insulin-dose calculator disk
|
AU2001259847B9
(en)
*
|
2000-05-12 |
2006-08-10 |
Oregon Health And Science University |
Method of treating immune pathologies with low dose estrogen
|
US7462486B2
(en)
*
|
2000-05-12 |
2008-12-09 |
Oregon Health & Science University |
Methods of selecting T cell receptor V peptides for therapeutic use
|
ATE367823T1
(de)
|
2000-05-24 |
2007-08-15 |
Us Health |
E-selectin zur behandlung oder vorbeugung von schlaganfall
|
US6867183B2
(en)
*
|
2001-02-15 |
2005-03-15 |
Nobex Corporation |
Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
|
US7060675B2
(en)
*
|
2001-02-15 |
2006-06-13 |
Nobex Corporation |
Methods of treating diabetes mellitus
|
JP2004533438A
(ja)
*
|
2001-05-04 |
2004-11-04 |
ファイザー・プロダクツ・インク |
エーロゾル化したインスリンによる2型糖尿病の予防法
|
US6828305B2
(en)
*
|
2001-06-04 |
2004-12-07 |
Nobex Corporation |
Mixtures of growth hormone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US6858580B2
(en)
*
|
2001-06-04 |
2005-02-22 |
Nobex Corporation |
Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US7713932B2
(en)
*
|
2001-06-04 |
2010-05-11 |
Biocon Limited |
Calcitonin drug-oligomer conjugates, and uses thereof
|
US6828297B2
(en)
*
|
2001-06-04 |
2004-12-07 |
Nobex Corporation |
Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US6713452B2
(en)
*
|
2001-06-04 |
2004-03-30 |
Nobex Corporation |
Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US6835802B2
(en)
*
|
2001-06-04 |
2004-12-28 |
Nobex Corporation |
Methods of synthesizing substantially monodispersed mixtures of polymers having polyethylene glycol moieties
|
US7196059B2
(en)
*
|
2001-09-07 |
2007-03-27 |
Biocon Limited |
Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
|
US20030198666A1
(en)
*
|
2002-01-07 |
2003-10-23 |
Richat Abbas |
Oral insulin therapy
|
WO2003080149A2
(en)
|
2002-03-20 |
2003-10-02 |
Mannkind Corporation |
Inhalation apparatus
|
ES2421520T3
(es)
*
|
2003-04-28 |
2013-09-03 |
Daiichi Sankyo Co Ltd |
Potenciador de la producción de adiponectina
|
US7772272B2
(en)
*
|
2003-04-28 |
2010-08-10 |
Daiichi Sankyo Company, Limited |
Method for enhancing glucose uptake into warm-blooded animal adipocytes
|
US7338171B2
(en)
*
|
2003-10-27 |
2008-03-04 |
Jen-Chuen Hsieh |
Method and apparatus for visual drive control
|
KR100985126B1
(ko)
*
|
2004-01-12 |
2010-10-05 |
맨카인드 코포레이션 |
제2형 당뇨병에서 혈청 프로인슐린 수치의 감소 방법
|
AU2005222613B2
(en)
*
|
2004-03-12 |
2009-12-17 |
Biodel, Inc. |
Rapid acting drug delivery compositions
|
US20080085298A1
(en)
*
|
2004-03-12 |
2008-04-10 |
Biodel, Inc. |
Rapid Mucosal Gel or Film Insulin Compositions
|
US20080096800A1
(en)
*
|
2004-03-12 |
2008-04-24 |
Biodel, Inc. |
Rapid mucosal gel or film insulin compositions
|
US20080090753A1
(en)
*
|
2004-03-12 |
2008-04-17 |
Biodel, Inc. |
Rapid Acting Injectable Insulin Compositions
|
JP5563735B2
(ja)
|
2004-06-16 |
2014-07-30 |
タケダ ファーマシューティカルズ ユー.エス.エー. インコーポレイティド |
Ppi多回剤形
|
UA103758C2
(ru)
|
2004-07-19 |
2013-11-25 |
Биокон Лимитед |
Конъюгаты олигомеров инсулина, их композиции и применение
|
CA2575604A1
(en)
*
|
2004-07-30 |
2006-02-02 |
Oregon Health And Science University |
Methods for detecting and treating autoimmune disorders
|
DE602005024413D1
(de)
|
2004-08-20 |
2010-12-09 |
Mannkind Corp |
Katalyse der diketopiperazinsynthese
|
ES2540886T3
(es)
|
2004-08-23 |
2015-07-14 |
Mannkind Corporation |
Sales de dicetopiperazina para la administración de fármacos
|
WO2006109312A2
(en)
*
|
2005-04-15 |
2006-10-19 |
Vascular Biogenics Ltd. |
Compositions containing beta 2-glycoprotein i-derived peptides for the prevention and/or treatment of vascular disease
|
KR101557502B1
(ko)
|
2005-09-14 |
2015-10-06 |
맨카인드 코포레이션 |
결정질 미립자 표면에 대한 활성제의 친화력의 증가를기반으로 하는 약물 제제의 방법
|
US7332604B2
(en)
|
2005-09-20 |
2008-02-19 |
Schering Corporation |
1-[[1-[(2-Amino-6-methyl-4-pyridinyl)methyl]-4-fluoro-4-piperidinyl]carbonyl]-4-[2-(2-pyridinyl)-3H-imidazo[4,5-b]pyridin-3-yl]piperidine
|
US7713929B2
(en)
|
2006-04-12 |
2010-05-11 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
US8084420B2
(en)
*
|
2005-09-29 |
2011-12-27 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
US20070086952A1
(en)
*
|
2005-09-29 |
2007-04-19 |
Biodel, Inc. |
Rapid Acting and Prolonged Acting Inhalable Insulin Preparations
|
AU2007216966C1
(en)
|
2006-02-22 |
2014-03-20 |
Mannkind Corporation |
A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
|
CA2649109A1
(en)
*
|
2006-04-12 |
2007-10-25 |
Biodel, Inc. |
Rapid acting and long acting insulin combination formulations
|
US8217025B2
(en)
*
|
2006-11-17 |
2012-07-10 |
Harbor Therapeutics, Inc. |
Drug screening and treatment methods
|
EP2134351B1
(en)
|
2007-03-13 |
2016-04-27 |
Nutrition 21, Inc. |
Methods and compositions for the sustained release of chromium
|
WO2008124522A2
(en)
*
|
2007-04-04 |
2008-10-16 |
Biodel, Inc. |
Amylin formulations
|
EA020466B1
(ru)
|
2007-06-04 |
2014-11-28 |
Синерджи Фармасьютикалз Инк. |
Агонисты гуанилатциклазы, пригодные для лечения желудочно-кишечных нарушений, воспаления, рака и других заболеваний
|
US8969514B2
(en)
|
2007-06-04 |
2015-03-03 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
|
WO2009002867A2
(en)
|
2007-06-26 |
2008-12-31 |
Nutrition 21, Inc. |
Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement
|
US8173158B2
(en)
|
2007-10-12 |
2012-05-08 |
Takeda Pharmaceuticals U.S.A., Inc. |
Methods of treating gastrointestinal disorders independent of the intake of food
|
BRPI0818004B8
(pt)
|
2007-10-16 |
2021-05-25 |
Biocon Ltd |
composição farmacêutica sólida administrável por via oral e o processo da mesma.
|
WO2009055331A2
(en)
|
2007-10-22 |
2009-04-30 |
Schering Corporation |
Bicyclic heterocycle derivatives and their use as modulators of the activity of gpr119
|
EP2077132A1
(en)
|
2008-01-02 |
2009-07-08 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Dispensing device, storage device and method for dispensing a formulation
|
AU2009204309B2
(en)
*
|
2008-01-04 |
2012-11-22 |
Biodel, Inc. |
Insulin formulations for insulin release as a function of tissue glucose levels
|
JP2011520969A
(ja)
|
2008-05-19 |
2011-07-21 |
シェーリング コーポレイション |
二環式ヘテロ環誘導体およびgpr119モジュレーターとしてのその使用
|
EP2810951B1
(en)
|
2008-06-04 |
2017-03-15 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
PL2293833T3
(pl)
*
|
2008-06-13 |
2016-08-31 |
Mannkind Corp |
Inhalator proszkowy i układ do dostarczania leku
|
US8485180B2
(en)
|
2008-06-13 |
2013-07-16 |
Mannkind Corporation |
Dry powder drug delivery system
|
EP2609954B1
(en)
|
2008-06-20 |
2021-12-29 |
MannKind Corporation |
An interactive apparatus for real-time profiling of inhalation efforts
|
WO2010009195A1
(en)
|
2008-07-16 |
2010-01-21 |
Schering Corporation |
Bicyclic heterocycle derivatives and use thereof as gpr119 modulators
|
ES2624828T3
(es)
|
2008-07-16 |
2017-07-17 |
Synergy Pharmaceuticals Inc. |
Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
|
WO2010027567A2
(en)
|
2008-07-23 |
2010-03-11 |
Schering Corporation |
Tricyclic spirocycle derivatives and methods of use thereof
|
TWI532497B
(zh)
|
2008-08-11 |
2016-05-11 |
曼凱公司 |
超快起作用胰島素之用途
|
US8361959B2
(en)
|
2008-10-03 |
2013-01-29 |
Merck Sharp & Dohme Corp. |
Spiro-imidazolone derivatives as glucagon receptor antagonists
|
CA2739491A1
(en)
|
2008-10-16 |
2010-04-22 |
Schering Corporation |
Azine derivatives and methods of use thereof
|
WO2010075068A1
(en)
|
2008-12-16 |
2010-07-01 |
Schering Corporation |
Pyridopyrimidine derivatives and methods of use thereof
|
EP2379562A1
(en)
|
2008-12-16 |
2011-10-26 |
Schering Corporation |
Bicyclic pyranone derivatives as nicotinic acid receptor agonists
|
EP2379565A1
(en)
|
2008-12-19 |
2011-10-26 |
Schering Corporation |
Piperidine and piperazine derivatives and methods of use thereof
|
EP2379564A1
(en)
|
2008-12-19 |
2011-10-26 |
Schering Corporation |
Bicyclic heterocyclic derivatives and methods of use thereof
|
AU2009330206A1
(en)
|
2008-12-23 |
2011-07-07 |
Merck Sharp & Dohme Corp. |
Pyrimidine derivatives as GPCR modttlators for use in the treatment of obesity and diabetes
|
JP2012513470A
(ja)
|
2008-12-23 |
2012-06-14 |
シェーリング コーポレイション |
二環式複素環誘導体及びその使用方法
|
WO2010075273A1
(en)
|
2008-12-23 |
2010-07-01 |
Schering Corporation |
Bicyclic heterocycle derivatives and methods of use thereof
|
US8314106B2
(en)
|
2008-12-29 |
2012-11-20 |
Mannkind Corporation |
Substituted diketopiperazine analogs for use as drug delivery agents
|
MA33064B1
(fr)
*
|
2009-01-28 |
2012-02-01 |
Smartcells Inc |
Systemes à base de conjugués pour administration contrôlée de médicaments
|
CN102316892B
(zh)
|
2009-02-12 |
2014-06-04 |
西马生物医学计划公司 |
心肌营养素-1用于治疗代谢病的用途
|
US9060927B2
(en)
*
|
2009-03-03 |
2015-06-23 |
Biodel Inc. |
Insulin formulations for rapid uptake
|
EP2405963B1
(en)
|
2009-03-11 |
2013-11-06 |
MannKind Corporation |
Apparatus, system and method for measuring resistance of an inhaler
|
JP2012520887A
(ja)
|
2009-03-18 |
2012-09-10 |
シェーリング コーポレイション |
ジアシルグリセロールアシルトランスフェラーゼの阻害剤としての二環式化合物
|
JP5670421B2
(ja)
|
2009-03-31 |
2015-02-18 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
コンポーネント表面のコーティング方法
|
AR076024A1
(es)
|
2009-04-03 |
2011-05-11 |
Schering Corp |
Derivados de heterociclos biciclicos puenteados y metodos de uso de los mismos
|
US8580807B2
(en)
|
2009-04-03 |
2013-11-12 |
Merck Sharp & Dohme Corp. |
Bicyclic piperidine and piperazine derivatives as GPCR modulators for the treatment of obesity, diabetes and other metabolic disorders
|
EP2432531B1
(de)
|
2009-05-18 |
2019-03-06 |
Boehringer Ingelheim International GmbH |
Adapter, inhalationseinrichtung und zerstäuber
|
KR20180079458A
(ko)
|
2009-06-12 |
2018-07-10 |
맨카인드 코포레이션 |
한정된 비표면적을 갖는 디케토피페라진 마이크로입자
|
EP2440553B1
(en)
|
2009-06-12 |
2017-08-23 |
Merck Sharp & Dohme Corp. |
Thiophenes as glucagon receptor antagonists, compositions, and methods for their use
|
EP2477498A4
(en)
|
2009-09-14 |
2013-02-27 |
Merck Sharp & Dohme |
DIACYLGLYCEROL ACYLTRANSFERASE INHIBITORS
|
WO2011043994A1
(en)
|
2009-10-08 |
2011-04-14 |
Schering Corporation |
Inhibitors of fatty acid binding protein (fabp)
|
WO2011053688A1
(en)
|
2009-10-29 |
2011-05-05 |
Schering Corporation |
Bridged bicyclic piperidine derivatives and methods of use thereof
|
US9016147B2
(en)
|
2009-11-03 |
2015-04-28 |
Mannkind Corporation |
Apparatus and method for simulating inhalation efforts
|
US20120232073A1
(en)
|
2009-11-23 |
2012-09-13 |
Santhosh Francis Neelamkavil |
Fused bicyclic pyrimidine derivatives and methods of use thereof
|
EP2503891B1
(en)
|
2009-11-23 |
2016-08-03 |
Merck Sharp & Dohme Corp. |
Pyrimidine ether derivatives and methods of use thereof
|
EP2503887B1
(en)
|
2009-11-24 |
2016-01-06 |
Merck Sharp & Dohme Corp. |
Substituted biaryl derivatives and methods of use thereof
|
US10016568B2
(en)
|
2009-11-25 |
2018-07-10 |
Boehringer Ingelheim International Gmbh |
Nebulizer
|
WO2011064163A1
(en)
|
2009-11-25 |
2011-06-03 |
Boehringer Ingelheim International Gmbh |
Nebulizer
|
CA2781792C
(en)
|
2009-11-25 |
2019-04-02 |
Boehringer Ingelheim International Gmbh |
Nebulizer
|
CA2801936C
(en)
|
2010-06-21 |
2021-06-01 |
Mannkind Corporation |
Dry powder drug delivery system and methods
|
WO2011160932A1
(en)
|
2010-06-24 |
2011-12-29 |
Boehringer Ingelheim International Gmbh |
Nebulizer
|
WO2012015692A2
(en)
|
2010-07-28 |
2012-02-02 |
Smartcells, Inc. |
Recombinantly expressed insulin polypeptides and uses thereof
|
US20130156720A1
(en)
|
2010-08-27 |
2013-06-20 |
Ironwood Pharmaceuticals, Inc. |
Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
|
US9616097B2
(en)
|
2010-09-15 |
2017-04-11 |
Synergy Pharmaceuticals, Inc. |
Formulations of guanylate cyclase C agonists and methods of use
|
US8603527B2
(en)
|
2010-10-25 |
2013-12-10 |
Signal Pharmaceuticals, Llc |
Pharmaceutical formulations of a substituted diaminopurine
|
WO2012119007A1
(en)
|
2011-03-01 |
2012-09-07 |
N21 Acquisition Holding, Llc |
Compositions of insulin and chromium for the treatment and prevention of diabetes, hypoglycemia and related disorders
|
EP2694402B1
(en)
|
2011-04-01 |
2017-03-22 |
MannKind Corporation |
Blister package for pharmaceutical cartridges
|
EP2694220B1
(de)
|
2011-04-01 |
2020-05-06 |
Boehringer Ingelheim International GmbH |
Medizinisches gerät mit behälter
|
US9827384B2
(en)
|
2011-05-23 |
2017-11-28 |
Boehringer Ingelheim International Gmbh |
Nebulizer
|
WO2012174472A1
(en)
|
2011-06-17 |
2012-12-20 |
Mannkind Corporation |
High capacity diketopiperazine microparticles
|
EP2776053A1
(en)
|
2011-10-24 |
2014-09-17 |
MannKind Corporation |
Methods and compositions for treating pain
|
WO2013152894A1
(de)
|
2012-04-13 |
2013-10-17 |
Boehringer Ingelheim International Gmbh |
Zerstäuber mit kodiermitteln
|
AU2013289957B2
(en)
|
2012-07-12 |
2017-02-23 |
Mannkind Corporation |
Dry powder drug delivery systems and methods
|
US9486433B2
(en)
|
2012-10-12 |
2016-11-08 |
Mochida Pharmaceuticals Co. Ltd. |
Compositions and methods for treating non-alcoholic steatohepatitis
|
EP2911690A1
(en)
|
2012-10-26 |
2015-09-02 |
MannKind Corporation |
Inhalable influenza vaccine compositions and methods
|
CA2905435A1
(en)
|
2013-03-15 |
2014-09-25 |
Synergy Pharmaceuticals Inc. |
Compositions useful for the treatment of gastrointestinal disorders
|
KR102499439B1
(ko)
|
2013-03-15 |
2023-02-13 |
맨카인드 코포레이션 |
미세결정성 디케토피페라진 조성물 및 방법
|
WO2014142364A2
(en)
|
2013-03-15 |
2014-09-18 |
Mochida Pharmaceutical Co., Ltd. |
Compositions and methods for treating non-alcoholic steatohepatitis
|
US10441560B2
(en)
|
2013-03-15 |
2019-10-15 |
Mochida Pharmaceutical Co., Ltd. |
Compositions and methods for treating non-alcoholic steatohepatitis
|
CA2905438A1
(en)
|
2013-03-15 |
2014-09-25 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase and their uses
|
PT3004138T
(pt)
|
2013-06-05 |
2024-06-18 |
Bausch Health Ireland Ltd |
Agonistas ultrapuros de guanilato ciclase c, método de produção e utilização dos mesmos
|
MX2020009878A
(es)
|
2013-07-18 |
2022-07-27 |
Mannkind Corp |
Composiciones farmaceuticas en polvo seco estables al calor y metodos.
|
JP2016530930A
(ja)
|
2013-08-05 |
2016-10-06 |
マンカインド コーポレイション |
通気装置及び方法
|
EP3030298B1
(en)
|
2013-08-09 |
2017-10-11 |
Boehringer Ingelheim International GmbH |
Nebulizer
|
PL2835146T3
(pl)
|
2013-08-09 |
2021-04-06 |
Boehringer Ingelheim International Gmbh |
Nebulizator
|
MX366852B
(es)
|
2013-10-04 |
2019-07-25 |
Merck Sharp & Dohme |
Conjugados de insulina sensibles a glucosa.
|
US10195374B2
(en)
|
2014-05-07 |
2019-02-05 |
Boehringer Ingelheim International Gmbh |
Container, nebulizer and use
|
US10307464B2
(en)
|
2014-03-28 |
2019-06-04 |
Mannkind Corporation |
Use of ultrarapid acting insulin
|
ES2913297T3
(es)
|
2014-05-07 |
2022-06-01 |
Boehringer Ingelheim Int |
Nebulizador
|
US10722666B2
(en)
|
2014-05-07 |
2020-07-28 |
Boehringer Ingelheim International Gmbh |
Nebulizer with axially movable and lockable container and indicator
|
KR102569494B1
(ko)
|
2014-07-15 |
2023-08-21 |
이슘 리서치 디벨롭먼트 컴퍼니 오브 더 히브루 유니버시티 오브 예루살렘 엘티디. |
Cd44의 단리된 폴리펩타이드 및 이의 사용
|
US10561806B2
(en)
|
2014-10-02 |
2020-02-18 |
Mannkind Corporation |
Mouthpiece cover for an inhaler
|
JP6884701B2
(ja)
|
2014-10-06 |
2021-06-09 |
シグナル ファーマシューティカルズ,エルエルシー |
置換アミノプリン化合物、その組成物、及びそれによる治療の方法
|
CA2936741C
(en)
|
2014-10-31 |
2018-11-06 |
Purdue Pharma |
Methods and compositions particularly for treatment of attention deficit disorder
|
CN109069532A
(zh)
|
2016-02-11 |
2018-12-21 |
营养21有限责任公司 |
含铬组合物用于改善健康和健身
|
MX2018011992A
(es)
|
2016-04-01 |
2019-01-24 |
Signal Pharm Llc |
Compuestos de aminopurina sustituida, composiciones de estos y metodos de tratamiento con estos.
|
SI3436019T1
(sl)
|
2016-04-01 |
2021-12-31 |
Signal Pharmaceuticals, Llc |
(1s,4s)-4-(2-(((3s,4r)-3-fluorotetrahidro-2h-piran-4-il)amino)-8-((2,4, 6-triklorofenil)amino)-9h-purin-9-il)-1-metilcikloheksane-1-karboksamid in metode uporabe
|
WO2019070827A1
(en)
|
2017-10-04 |
2019-04-11 |
Celgene Corporation |
PROCESSES FOR THE PREPARATION OF CIS-4 [2 - {(3S, 4R) -3-FLUOROOXAN-4-YL] AMINO) -8- (2,4,6-TRICHLOROANILINO) -9H-PURIN-9-YL] -1 -MÉTHYLCYCLOHEXANE-1-carboxamide
|
US10543214B2
(en)
|
2017-10-04 |
2020-01-28 |
Celgene Corporation |
Compositions and methods of use of cis-4-[2-{[(3S,4R)-3-fluorooxan-4-yl]amino}-8-(2,4,6-trichloroanilino)-9H-purin-9-yl]-1-methylcyclohexane-1-carboxamide
|
US10722473B2
(en)
|
2018-11-19 |
2020-07-28 |
Purdue Pharma L.P. |
Methods and compositions particularly for treatment of attention deficit disorder
|
WO2023200363A1
(ru)
*
|
2022-04-13 |
2023-10-19 |
Фания Иршатовна МАГАНОВА |
Способ получения пероральной формы субстанции, содержащей инсулин
|